Charles Schwab’s Nutraceutical International Co NUTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-17,300
Closed -$721K 3124
2017
Q2
$721K Sell
17,300
-4,270
-20% -$152K ﹤0.01% 2572
2017
Q1
$672K Hold
21,570
﹤0.01% 2547
2016
Q4
$754K Hold
21,570
﹤0.01% 2516
2016
Q3
$674K Hold
21,570
﹤0.01% 2521
2016
Q2
$500K Buy
21,570
+4,270
+25% +$102K ﹤0.01% 2588
2016
Q1
$422K Hold
17,300
﹤0.01% 2642
2015
Q4
$447K Hold
17,300
﹤0.01% 2696
2015
Q3
$409K Hold
17,300
﹤0.01% 2700
2015
Q2
$429K Hold
17,300
﹤0.01% 2731
2015
Q1
$341K Hold
17,300
﹤0.01% 2790
2014
Q4
$373K Hold
17,300
﹤0.01% 2750
2014
Q3
$362K Hold
17,300
﹤0.01% 2715
2014
Q2
$413K Hold
17,300
﹤0.01% 2714
2014
Q1
$450K Hold
17,300
﹤0.01% 2628
2013
Q4
$464K Hold
17,300
﹤0.01% 2616
2013
Q3
$416K Hold
17,300
﹤0.01% 2617
2013
Q2
$370K Buy
+17,300
New +$327K ﹤0.01% 2645

Charles Schwab's NUTR Position: Q3 2017 in Review

Charles Schwab sold out of Nutraceutical International Co (NUTR) in Q3 2017, closing a stake of 17,300 shares — an estimated $721K sold.

Charles Schwab first reported a position in NUTR in Q2 2013 and held it in 17 quarters. The position peaked at $754K in Q4 2016. 0 funds tracked by Wall St. Rank hold NUTR as of Q3 2017.

  • Charles Schwab reported no remaining Nutraceutical International Co position as of Q3 2017 after selling out during the quarter.
  • Charles Schwab sold 17,300 Nutraceutical International Co shares in Q3 2017, an estimated $721K.
  • Charles Schwab first reported a position in Nutraceutical International Co in Q2 2013 and held it in 17 quarters.
  • Charles Schwab's Nutraceutical International Co position peaked at $754K in Q4 2016.
  • 0 funds tracked by Wall St. Rank held Nutraceutical International Co as of Q3 2017.

Based on Charles Schwab's 13F filing for Q3 2017, filed 13 Nov 2017.